This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 5,383 
1 out of 1,853 
Years Active: 2011
Title: Ivan Moura: Innovator in Antibody Research
Introduction
Ivan Moura is a prominent inventor based in Paris, France. He is known for his significant contributions to the field of antibody research, particularly in the development of monoclonal antibodies. His work has implications for medical treatments, especially in the area of cancer therapy.
Latest Patents
Ivan Moura holds a patent for an Anti TfR antibody. This invention relates to the monoclonal antibody A24, which is directed against the transferrin receptor. The antibody is particularly useful as an antiproliferative agent, showcasing its potential in therapeutic applications.
Career Highlights
Throughout his career, Ivan Moura has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. His experience in these organizations has allowed him to advance his research and contribute to significant scientific advancements.
Collaborations
Ivan Moura has collaborated with notable colleagues, including Renato Monteiro and Olivier Hermine. These partnerships have enriched his research endeavors and fostered innovation in the field of antibody development.
Conclusion
Ivan Moura's work in antibody research exemplifies the impact of innovative thinking in medical science. His contributions continue to pave the way for advancements in therapeutic treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile